COVID-19: HHS-NIH-NIAID-BAA2020-1: Research Area 004, Development of Therapeutic Products for Biodefense, Anti-Microbial Resistant (AMR) Infections and Emerging Infectious Diseases
Award Notice Posted
- Solicitation number
- HHS-NIH-NIAID-BAA2020-1
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to The Leland Stanford Junior University
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93020C00054 Federal contract award
Notice details come from SAM.gov. Updated .
About this opportunity
This cost-reimbursement contract valued at $48,650,083 was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Leland Stanford Junior University on May 17, 2021 to support research area 004, which focuses on the development of therapeutic products for biodefense, anti-microbial resistant infections and emerging infectious diseases. The contract was awarded under full and open competition and selected on a cost-reimbursement basis given the inability to adequately define costs at the time of award.
Notice text
2 versions
Update #2 · Latest ·
COVID-19: This cost-reimbursement contract award was made under full and open competition. This type of contract was selected because costs cannot be adequately defined at the time of contract award. This contract is to develop small synthetic chemical molecules as broadly active antiviral for the treatment of viral infections.
Awarded contract 75N93020C00054 to LELAND STANFORD JUNIOR UNIVERSITY, THE for 48865083.00 on 2020-08-28.
Update #1 ·
This cost-reimbursement contract award was made under full and open competition. This type of contract was selected because costs cannot be adequately defined at the time of contract award.
Awarded contract 75N93020C00054 to LELAND STANFORD JUNIOR UNIVERSITY, THE for 48865083.00 on 2020-08-28.
Notice history
| Notice | Type | Posted |
|---|---|---|
| 2020 NIAID Omnibus Broad Agency Announcement | Award Notice | |
| 2020 NIAID Omnibus Broad Agency Announcement | Award Notice | |
| 2020 NIAID Omnibus Broad Agency Announcement | Award Notice | |
| This notice | Award Notice | |
| 2020 NIAID Omnibus Broad Agency Announcement | Solicitation | |
| 2020 NIAID Omnibus Broad Agency Announcement | Pre-Solicitation |
6 of 11 notices listed here. See the rest on GovTribe.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity